Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial

PHASE3RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 23, 2024

Primary Completion Date

June 29, 2029

Study Completion Date

June 29, 2029

Conditions

Pancreas CancerOligometastatic

Interventions

RADIATION

Consolidative Radiation

Participants will receive treatment through radiation therapy

Trial Locations (1)

RECRUITING

MD Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER